Hao Jianli, Zhang Weiqing, Tong Rui, Huang Zeqing
Department of Anesthesiology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, PR China.
Department of Oncologynecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, PR China.
ACS Omega. 2021 Feb 15;6(8):5471-5478. doi: 10.1021/acsomega.0c05708. eCollection 2021 Mar 2.
: A high risk of brain injury has been reported with the usage of general anesthetics such as propofol in infants. Experimental data indicated that oxidative stress and inflammation are involved in the neurotoxicity induced by propofol. Febuxostat is a novel anti-gout agent recently reported to exert an anti-inflammatory effect. The present study aims to investigate the protective property of febuxostat against the cytotoxicity of propofol in brain endothelial cells as well as the underlying preliminary mechanism. : The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was utilized to screen the optimized incubation concentration of febuxostat. bEnd.3 brain endothelial cells were stimulated with 2% propofol in the presence or absence of febuxostat (10, 20 μM) for 24 h. The lactate dehydrogenase (LDH) release assay was conducted to detect cytotoxicity. The reactive oxygen species (ROS) levels were evaluated using dichloro-dihydro-fluorescein diacetate (DCFH-DA) staining, and the concentration of reduced glutathione (GSH) was determined using a commercial kit. The expressions of TNF-α, IL-6, IL-12, CXCL-1, PDPN, CXCL8, VCAM-1, and E-selectin were determined using a quantitative real-time polymerase chain reaction (qRT-PCR) and an enzyme-linked immunosorbent assay (ELISA). Western blot and qRT-PCR were utilized to determine the expressions of COX-2 and KLF6. The production of PGE was evaluated by ELISA. : First, increased LDH release induced by propofol was significantly suppressed by febuxostat. The oxidative stress (elevated ROS levels and decreased GSH level) induced by propofol was alleviated by febuxostat. Second, the upregulated inflammatory factors (TNF-α, IL-6, and IL-12), pro-inflammatory chemokines (CXCL-1, PDPN, and CXCL8), adhesion molecules (VCAM-1 and E-selectin), and inflammatory mediators (COX-2 and PGE) induced by propofol were greatly downregulated by febuxostat. Lastly, the expression of KLF6 was significantly suppressed by propofol but greatly elevated by febuxostat. : Febuxostat prevented the cytotoxicity of propofol in brain endothelial cells by alleviating oxidative stress and inflammatory response through KLF6.
据报道,婴儿使用丙泊酚等全身麻醉剂会有较高的脑损伤风险。实验数据表明,氧化应激和炎症参与了丙泊酚诱导的神经毒性。非布司他是一种最近报道具有抗炎作用的新型抗痛风药物。本研究旨在探讨非布司他对脑内皮细胞中丙泊酚细胞毒性的保护作用及其潜在的初步机制。
采用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法筛选非布司他的最佳孵育浓度。在存在或不存在非布司他(10、20 μM)的情况下,用2%丙泊酚刺激bEnd.3脑内皮细胞24小时。进行乳酸脱氢酶(LDH)释放试验以检测细胞毒性。使用二氯二氢荧光素二乙酸酯(DCFH-DA)染色评估活性氧(ROS)水平,并使用商业试剂盒测定还原型谷胱甘肽(GSH)的浓度。使用定量实时聚合酶链反应(qRT-PCR)和酶联免疫吸附测定(ELISA)测定TNF-α、IL-6、IL-12、CXCL-1、PDPN、CXCL8、VCAM-1和E-选择素的表达。使用蛋白质印迹法和qRT-PCR测定COX-2和KLF6的表达。通过ELISA评估PGE的产生。
首先,非布司他显著抑制了丙泊酚诱导的LDH释放增加。非布司他减轻了丙泊酚诱导的氧化应激(ROS水平升高和GSH水平降低)。其次,非布司他大大下调了丙泊酚诱导的炎症因子(TNF-α、IL-6和IL-12)、促炎趋化因子(CXCL-1、PDPN和CXCL8)、黏附分子(VCAM-1和E-选择素)和炎症介质(COX-2和PGE)的上调。最后,丙泊酚显著抑制KLF6的表达,但非布司他使其大大升高。
非布司他通过KLF6减轻氧化应激和炎症反应,从而预防丙泊酚对脑内皮细胞的细胞毒性。